Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 213819-48-8 Chemical Structure| 213819-48-8

Structure of Belotecan HCl
CAS No.: 213819-48-8

Chemical Structure| 213819-48-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Belotecan hydrochloride, a synthetic and water-soluble camptothecin derivative, is inhibitor of topoisomerase I.

Synonyms: (S)-CKD602; 7-[2-(N-isopropylamino)ethyl]-(20S)-Camptothecin; Belotecan (hydrochloride)

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Belotecan HCl

CAS No. :213819-48-8
Formula : C25H28ClN3O4
M.W : 469.96
SMILES Code : O=C1[C@](O)(CC)C2=C(CO1)C(N3CC4=C(CCNC(C)C)C5=CC=CC=C5N=C4C3=C2)=O.[H]Cl
Synonyms :
(S)-CKD602; 7-[2-(N-isopropylamino)ethyl]-(20S)-Camptothecin; Belotecan (hydrochloride)
MDL No. :MFCD07772313
InChI Key :SJKBXKKZBKCHET-UQIIZPHYSA-N
Pubchem ID :6918340

Safety of Belotecan HCl

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H301
Precautionary Statements:P501-P270-P264-P301+P310+P330-P405
Class:6.1
UN#:2811
Packing Group:

Related Pathways of Belotecan HCl

DNA

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
SiHa cells 150 ng/ml 48 h Induced apoptosis and G2/M phase cell cycle arrest, increased expression of PARP, cleaved PARP, BAX, and phosphorylated p53. Mol Med. 2019 May 28;25(1):23
SNU-601 0.1875 μg/ml 24 h Evaluate the growth inhibitory effect of Belotecan on SNU-601 cells, IC50 value was 0.1875 μg/ml. Cancer Res Treat. 2006;38(3):159-67
SNU-16 0.1875 μg/ml 24 h Evaluate the growth inhibitory effect of Belotecan on SNU-16 cells, IC50 value was 0.1875 μg/ml. Cancer Res Treat. 2006;38(3):159-67
SNU-5 0.09375 μg/ml 24 h Evaluate the growth inhibitory effect of Belotecan on SNU-5 cells, IC50 value was 0.09375 μg/ml. Cancer Res Treat. 2006;38(3):159-67
YD-38 (lower gingiva) 0.05 µg/ml 72 h Evaluate the inhibitory effect of Belotecan on YD-38 cell proliferation, showing 50% inhibition of cell viability after 72 hours. Oncol Lett. 2015 Jan;9(1):136-142
YD-9 (buccal mucosa) 0.18 µg/ml 72 h Evaluate the inhibitory effect of Belotecan on YD-9 cell proliferation, showing 50% inhibition of cell viability after 72 hours. Oncol Lett. 2015 Jan;9(1):136-142
YD-8 (tongue) 2.4 µg/ml 72 h Evaluate the inhibitory effect of Belotecan on YD-8 cell proliferation, showing 50% inhibition of cell viability after 72 hours. Oncol Lett. 2015 Jan;9(1):136-142

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
BALB/c nude mice SKpac-13 cell xenograft model Belotecan intraperitoneal injection, AZD6738 oral gavage 10 mg/kg Belotecan every 4 days, AZD6738 daily (later adjusted to 2 days on/2 days off), for 90 days To evaluate the in vivo anti-tumor efficacy of Belotecan in combination with AZD6738. Results showed that the combination treatment group exhibited greater tumor growth inhibition compared to Belotecan or AZD6738 alone. Int J Mol Sci. 2021 Jan 27;22(3):1223
BALB/c-nude mice CaSki cell xenograft model Intravenous injection 25 mg/kg Every 4 days for 16 days Significantly inhibited tumor growth with no significant effect on body weight. Mol Med. 2019 May 28;25(1):23

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.13mL

0.43mL

0.21mL

10.64mL

2.13mL

1.06mL

21.28mL

4.26mL

2.13mL

References

 

Historical Records

Categories